asparlas is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Servier Pharmaceuticals Llc. The primary component is Calaspargase Pegol.
| Product ID | 72694-515_25fc7d15-4a8f-4c12-a603-aeeac73e4998 |
| NDC | 72694-515 |
| Product Type | Human Prescription Drug |
| Proprietary Name | asparlas |
| Generic Name | Calaspargase Pegol |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2019-09-27 |
| Marketing Category | BLA / BLA |
| Application Number | BLA761102 |
| Labeler Name | Servier Pharmaceuticals LLC |
| Substance Name | CALASPARGASE PEGOL |
| Active Ingredient Strength | 750 U/mL |
| Pharm Classes | Asparaginase [CS],Asparagine-specific Enzyme [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2019-09-27 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA761102 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-09-27 |
| Ingredient | Strength |
|---|---|
| CALASPARGASE PEGOL | 750 U/mL |
| SPL SET ID: | 6585bd0d-bd78-4341-9e87-0f7664821f05 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ASPARLAS 87452086 5950575 Live/Registered |
SERVIER IP UK LIMITED 2017-05-16 |